Cited 0 times in
Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: a study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase 2a clinical trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.